| __timestamp | ADMA Biologics, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 5915545 | 1288519000 |
| Thursday, January 1, 2015 | 7177633 | 1465761000 |
| Friday, January 1, 2016 | 10661037 | 1598800000 |
| Sunday, January 1, 2017 | 22760560 | 1725300000 |
| Monday, January 1, 2018 | 16985290 | 1627800000 |
| Tuesday, January 1, 2019 | 29349083 | 1448800000 |
| Wednesday, January 1, 2020 | 42219783 | 1483300000 |
| Friday, January 1, 2021 | 80942625 | 1685500000 |
| Saturday, January 1, 2022 | 154079692 | 1936300000 |
| Sunday, January 1, 2023 | 258214999 | 2327500000 |
Data in motion
In the dynamic world of biotechnology, United Therapeutics Corporation and ADMA Biologics, Inc. have carved distinct paths over the past decade. From 2014 to 2023, United Therapeutics consistently demonstrated robust financial health, with revenue peaking at approximately $2.3 billion in 2023, marking an impressive 80% increase from 2014. This growth underscores their strategic prowess in the biotech sector.
Conversely, ADMA Biologics, Inc. embarked on a remarkable growth journey, with revenues skyrocketing by over 4,200% from 2014 to 2023. Starting from a modest base, ADMA's revenue reached around $258 million in 2023, reflecting their aggressive expansion and innovation in the field.
This comparative analysis highlights the diverse strategies and market positions of these two companies, offering valuable insights into the evolving landscape of biotechnology.
Amgen Inc. vs United Therapeutics Corporation: Examining Key Revenue Metrics
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs United Therapeutics Corporation
Breaking Down Revenue Trends: United Therapeutics Corporation vs Bio-Techne Corporation
Annual Revenue Comparison: United Therapeutics Corporation vs Veracyte, Inc.
Annual Revenue Comparison: United Therapeutics Corporation vs MorphoSys AG
Breaking Down Revenue Trends: United Therapeutics Corporation vs Mesoblast Limited
Revenue Showdown: United Therapeutics Corporation vs Taro Pharmaceutical Industries Ltd.
United Therapeutics Corporation vs Novavax, Inc.: Examining Key Revenue Metrics
Pharming Group N.V. vs ADMA Biologics, Inc.: Examining Key Revenue Metrics
ADMA Biologics, Inc. and Vericel Corporation: A Comprehensive Revenue Analysis
Who Generates More Revenue? ADMA Biologics, Inc. or Dynavax Technologies Corporation
Revenue Showdown: ADMA Biologics, Inc. vs Novavax, Inc.